 |
|
Rate of Resolution of Exudative Retinal Detachment After Plaque Radiotherapy for Uveal Melanoma
J. William Harbour, MD;
Saad Ahmad, MD;
Mohammed El-Bash, MD
Arch Ophthalmol. 2002;120:1463-1469.
Objectives To determine the clinical relevance of exudative retinal detachment (ERD) and the rate of ERD resolution after plaque radiotherapy of posterior uveal melanomas.
Methods Retrospective, nonrandomized study of 135 consecutive patients with posterior uveal melanoma treated by iodine 125 plaque radiotherapy. Extent of ERD and tumor thickness were assessed before radiotherapy and at postoperative follow-up visits. Local tumor control was assessed at each follow-up visit.
Results An ERD was present in 71 patients (53%) and was a risk factor for local treatment failure (P = .03). The ERD resolved after radiotherapy in 59 (83%) of the 71 patients. The ERD resolved within 1 year in 64 patients (90%) (mean time to resolution, 5.6 months). The rate of ERD resolution correlated with the rate of decrease in tumor thickness (P = .004). The ERD did not resolve and the tumor thickness continued to increase in 5 patients, who required further intervention. A recurrent retinal detachment developed in 5 patients, who were diagnosed as having rhegmatogenous retinal detachment (3 patients) and lipid exudation secondary to tumor vasculopathy (2 patients). Two patients with local tumor recurrence did not develop a recurrent ERD. Local tumor control was achieved in 130 patients (96%).
Conclusions An ERD may be a risk factor for local failure after plaque radiotherapy for uveal melanoma. If an ERD does not resolve within 9 to 12 months of radiotherapy and the tumor is not regressing, treatment failure should be suspected. A recurrent ERD does not necessarily represent local tumor recurrence.
From the Center for Ocular Oncology, Department of Ophthalmology and Visual Sciences, Washington University and Barnes Retina Institute, St Louis, Mo.
|
